NICORANDIL DERIVATE
European patent · EP3937938 · Deleted
Register entry
- Publication number
- EP3937938
- Application number
- EP20720153
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- Deleted
- Specification
- Granted
- Filed
- Mar 16, 2020
- Published
- Jan 19, 2022
- Granted
- Jan 28, 2026
- Deleted
- Oct 23, 2026
- Reason
- Annual fee unpaid
- IPC classes
- A61K 31/455 (2006.01)A61P 13/12 (2006.01)
- Priority
- US 201962819372 P 15.03.2019
- PCT application
- PCT/US2020/023016 16.03.2020
- PCT publication
- WO2020/190890 24.09.2020
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Oct 23, 2026
Deleted, fee unpaid
- Status of protective title
- Active → Cancelled
- Cancellation date
- 23.10.2026
- Cause for cancellation
- Non-payment of renewal fee
Published in Swissreg on 23.10.2026
- Apr 30, 2026
Owner
- Owner
- Unicycive Therapeutics Inc., 4300 El Camino Real, Suite 210, Los Altos, CA 94022, USA → Unicycive Therapeutics Inc., 1975 W. El Camino Real, Suite 204, Mountain View, CA 94040, USA
Published in Swissreg on 30.04.2026
- Jan 28, 2026
Granted
- Specification status
- Non-published patent application → Granted patent
- Status of protective title
- Initiated → Active
Published in Swissreg on 28.01.2026
Parties
Inventor
GUPTA, Shalabh
Mountain View, CA 94040, US
DUGAR, Sundeep
San Jose, CA 95120, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.